Patient characteristics by histologic subtype
Characteristic . | Overall, n . | Nodular sclerosis, n . | Mixed cellularity, n . | Lymphocyte depleted, n . | Not classified, n . |
---|---|---|---|---|---|
No. of patients | 216 | 185 | 19 | 3 | 9 |
Age | |||||
10 years or less | 26 | 18 | 4 | 0 | 4 |
11-15 years | 122 | 106 | 11 | 1 | 4 |
16-20 years | 68 | 61 | 4 | 2 | 1 |
Male sex | 140 | 113 | 17 | 3 | 7 |
Stage | |||||
IB*/II | 82 | 76 | 3 | 0 | 3 |
III | 52 | 41 | 8 | 2 | 1 |
IV | 70 | 58 | 7 | 1 | 4 |
Unknown | 12 | 10 | 1 | 0 | 1 |
Response to 3 cycles | 209 | 180 | 19 | 3 | 7 |
Not RER | 77 | 67 | 6 | 0 | 4 |
RER/CR | 88 | 75 | 9 | 2 | 2 |
RER/less than CR | 44 | 38 | 4 | 1 | 1 |
Unknown | 7 | 5 | 0 | 0 | 2 |
Characteristic . | Overall, n . | Nodular sclerosis, n . | Mixed cellularity, n . | Lymphocyte depleted, n . | Not classified, n . |
---|---|---|---|---|---|
No. of patients | 216 | 185 | 19 | 3 | 9 |
Age | |||||
10 years or less | 26 | 18 | 4 | 0 | 4 |
11-15 years | 122 | 106 | 11 | 1 | 4 |
16-20 years | 68 | 61 | 4 | 2 | 1 |
Male sex | 140 | 113 | 17 | 3 | 7 |
Stage | |||||
IB*/II | 82 | 76 | 3 | 0 | 3 |
III | 52 | 41 | 8 | 2 | 1 |
IV | 70 | 58 | 7 | 1 | 4 |
Unknown | 12 | 10 | 1 | 0 | 1 |
Response to 3 cycles | 209 | 180 | 19 | 3 | 7 |
Not RER | 77 | 67 | 6 | 0 | 4 |
RER/CR | 88 | 75 | 9 | 2 | 2 |
RER/less than CR | 44 | 38 | 4 | 1 | 1 |
Unknown | 7 | 5 | 0 | 0 | 2 |
Stage IB, n = 1.